IgE, blood eosinophils and FeNO are not enough for choosing a monoclonal therapy among the approved options in patients with type 2 severe asthma

por Sánchez, Jorge, Morales, Edison, Santamaria, Luis-Carlos, Acevedo, Ana-Milena, Calle, Ana, Olivares, Margarita, Gomez, Carolina, Amaya, Daniel, Cardona, Ricardo
Publicado 2021